Asia Pacific Respiratory Disease Testing Market Size & Outlook
Asia Pacific respiratory disease testing market, 2018-2030 (US$M)
Asia Pacific respiratory disease testing market highlights
- The Asia Pacific respiratory disease testing market generated a revenue of USD 1,607.2 million in 2023.
- The market is expected to grow at a CAGR of 4.2% from 2024 to 2030.
- In terms of segment, imaging tests was the largest revenue generating product in 2023.
- Imaging Tests is the most lucrative product segment registering the fastest growth during the forecast period.
Asia Pacific data book summary
| Market revenue in 2023 | USD 1,607.2 million |
| Market revenue in 2030 | USD 2,146.9 million |
| Growth rate | 4.2% (CAGR from 2023 to 2030) |
| Largest segment | Imaging tests |
| Fastest growing segment | Imaging Tests |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Imaging Tests |
| Key market players worldwide | Abbott Laboratories, Becton Dickinson & Co, Koninklijke Philips NV, ResMed Inc, Fisher & Paykel Healthcare Corp Ltd, Medtronic PLC, BioMerieux SA, Siemens Healthineers AG ADR, Carestream Health - HCIS business |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 25.2% of the global respiratory disease testing market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,146.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Respiratory Disease Testing Market Scope
Respiratory Disease Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific respiratory disease testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to respiratory disease testing market will help companies and investors design strategic landscapes.
Imaging tests was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Asia Pacific respiratory disease testing market based on imaging tests covering the revenue growth of each sub-segment from 2018 to 2030.
in consumer awareness are driving market growth in this region. In addition, rising prevalence of infectious diseases, increasing demand for diagnostic products, and growing population base significantly contribute to market growth.
Asia Pacific markets such as China, Australia, Korea, and Taiwan already have a healthcare reimbursement system that provides an inclusive coverage for diagnostic tests. Increasing initiatives for scientific research, and positive economic growth coupled with high unmet needs are some primary growth drivers of this market.
Moreover, improving healthcare regulatory scenario in the high growth countries is expected to attract international players to invest and capitalize on the available opportunities. Positive changes, such as healthcare benefits by government, increased awareness amongst the population, and an urge to avail high-end medical treatment are also expected to drive regional market growth.
Reasons to subscribe to Asia Pacific respiratory disease testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific respiratory disease testing market databook
-
Our clientele includes a mix of respiratory disease testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific respiratory disease testing market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific respiratory disease testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific respiratory disease testing market
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
